High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements

general

14

Centers

14

Active Trials

—

Cancer Funding

Specific Cancer Types(2)

NameCenters
Recurrent High Grade B-Cell Lymphoma with MYC and BCL6 Rearrangements—
Refractory High Grade B-Cell Lymphoma with MYC and BCL6 Rearrangements—

Top Centers for High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements(14)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Siteman Cancer CenterSt. Louis, MO
NCI Comprehensive
Active Research Program
53.6
2
Yale Cancer Center Yale School of MedicineNew Haven, CT
NCI Comprehensive
Active Research Program
53.6
3
The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL
NCI Comprehensive
Active Research Program
53.6
4
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
Active Research Program
53.6
5
University of Virginia Cancer CenterCharlottesville, VA
NCI Comprehensive
Active Research Program
53.6
6
The University of Arizona Cancer CenterTucson, AZ
NCI Comprehensive
Active Research Program
53.6
7
Medical College of Wisconsin Cancer CenterMilwaukee, WI
Active Research Program
53.6
8
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
53.6
9
VCU Massey Comprehensive Cancer CenterRichmond, VA
NCI Comprehensive
Active Research Program
53.6
10
Fred & Pamela Buffett Cancer CenterOmaha, NE
NCI Clinical
Active Research Program
53.6
11
University of Illinois Cancer CenterChicago, IL
Active Research Program
53.6
12
Cancer Center at IllinoisUrbana, IL
Active Research Program
53.6
13
University of Cincinnati Cancer CenterCincinnati, OH
Active Research Program
53.6
14
The University of Vermont Cancer CenterBurlington, VT
Active Research Program
53.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →